Muscle Blood Flow During Exercise

NCT ID: NCT02070848

Last Updated: 2021-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-01

Study Completion Date

2018-10-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Physical exercise triggers various physiological responses including a marked increase in muscle blood flow and oxygen delivery in order to support muscle activity. How muscle blood flow is controlled is currently unclear.

The primary purpose of this study is to establish the respective contribution of metabolic (linked to energy requirements) and mechanical (linked to muscle tensions) signals in the exercise hyperemia and the possible role of the red blood cells.

Vasodilation and muscle blood flow during exercise are controlled by ATP released in the plasma from the red blood cells in response to a combination of metabolic and mechanical signals applied on the vasculature.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skeletal Muscle Blood Flow

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Concentric vs eccentric

One arm study in which each subject will act as his own control.

Session 1-4

Intervention Type OTHER

Familiarization sessions to knee-extensor exercise separated by 72h recovery

Session 4

Intervention Type OTHER

After the last familiarization session, 1 maximal incremental test on a bicycle, followed by 72h rest

Session 5

Intervention Type OTHER

2 maximal incremental tests of knee-extension exercise (concentric vs eccentric), separated by 3h rest.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Session 1-4

Familiarization sessions to knee-extensor exercise separated by 72h recovery

Intervention Type OTHER

Session 4

After the last familiarization session, 1 maximal incremental test on a bicycle, followed by 72h rest

Intervention Type OTHER

Session 5

2 maximal incremental tests of knee-extension exercise (concentric vs eccentric), separated by 3h rest.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non smoker or having stopped smoking for at least 5 yr
* Practice sports: physical activity level will be evaluated with a questionnaire (de Baecke et coll., 1982) and will give an activity index greater than 6 together with a VO2max greater than 50 ml/kg/min
* Body mass index lower than 25
* Registered to the French Social Security system
* Providing a written and informed consent to participate in the study

Exclusion Criteria

* History of venous or arterial thrombo-embolic events
* Bad perfusion from the cubital artery
* Unable to understand the information notice
* Subject exposed to law investigations or with financial dependancy
* Subjects feeling unwell whan seing blood.
* Subjects advised to not practice sport.
* Musculo-tendinous or articular issues with the lower leg
* Respiratory, cardiovascular or metabolic pathologies
* Current medical treatment that can not be stopped 7 days before the experiment.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stéphane DOUTRELEAU, MD

Role: PRINCIPAL_INVESTIGATOR

Hôpitaux Universitaires de Strasbourg

DUFOUR Stéphane, MD

Role: STUDY_DIRECTOR

Faculté des Sciences du Sport 14 Rue René Descartes 67084 Strasbourg

FAVRET Fabrice, MD

Role: STUDY_CHAIR

Faculté des Sciences du Sport 14 Rue René Descartes 67084 Strasbourg

LONSDORFER Evelyne, MD

Role: PRINCIPAL_INVESTIGATOR

Hôpitaux Universitaires de Strasbourg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SERVICE DE PHYSIOLOGIE ET D'EXPLORATIONS FONCTIONNELLES - Nouvel Hôpital Civil

Strasbourg, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5456

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Iron Status and Human Metabolism
NCT02308449 COMPLETED NA